BT
Bernard Thienpont
KU Leuven, VIB Vesalius Research Center, Katholieke Universiteit Leuven, Babraham Institute
0000-0002-8772-6845
Employment
-
KU Leuven Professor2017 - Present
-
VIB Vesalius Research Center Post-doctoral research scientist2012 - 2017
-
Babraham Institute Post-doctoral research scientist2009 - 2012
-
Katholieke Universiteit Leuven Faculteit Geneeskunde Doctoral Research Fellow2005 - 2009
Education
-
Katholieke Universiteit Leuven PhD in Medicine2005 - 2009
-
Katholieke Universiteit Leuven Master of Business Economics2003 - 2004
-
Katholieke Universiteit Leuven Master of Science (Master in de bio-ingenieurswetenschappen: cel- en gentechnologie)1998 - 2003
Projects & Funding
Projects & funding information is unavailable.
Publications (275)
- CELL-FREE DNA METHYLATION FOR NON-INVASIVE DIAGNOSTICS: ADVANCING DISEASE DETECTION THROUGH INTEGRATIVE ANALYSES Save
- Cell-free DNA fragmentome analysis informs pregnancy outcome in patients with immune-mediated disease Save
- Data from Prenatal Exposure to Chemotherapy Increases the Mutation Burden in Human Neonatal Hematopoietic Stem Cells Save
- Figure S1 from Prenatal Exposure to Chemotherapy Increases the Mutation Burden in Human Neonatal Hematopoietic Stem Cells Save
- Figure S2 from Prenatal Exposure to Chemotherapy Increases the Mutation Burden in Human Neonatal Hematopoietic Stem Cells Save
- Figure S3 from Prenatal Exposure to Chemotherapy Increases the Mutation Burden in Human Neonatal Hematopoietic Stem Cells Save
- Figure S4 from Prenatal Exposure to Chemotherapy Increases the Mutation Burden in Human Neonatal Hematopoietic Stem Cells Save
- Figure S5 from Prenatal Exposure to Chemotherapy Increases the Mutation Burden in Human Neonatal Hematopoietic Stem Cells Save
- Tables S1-3 from Prenatal Exposure to Chemotherapy Increases the Mutation Burden in Human Neonatal Hematopoietic Stem Cells Save
- ERBB4 activation as a new therapy for atrial remodeling and fibrillation. Save